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A new development in the management of
pituitary tumors is the transsphenoidal technique. It
will be my purpose to show that it provides an elegant
way of handling the great majority of pituitary
problems, at least the ones that I have encountered,
although it has its shortcomings as well as its
advantages.
Pituitary tumors manifest themselves in two
ways-by compressing structures in the neighborhood, primarily the optic nerves and chiasm
and by the two endocrine manifestations, one being
the compression of the normal pituitary gland to
produce varying degrees of hypopituitarism and the
other, the hyperfunctioning adenoma. A large tumor
with a suprasellar extension compresses the optic
chiasm and optic nerves; obviously, a tumor of this
size would also cause a degree of hypopituitarism. A
smaller tumor, a microadenoma, can express itself by
hypersecretion of a hormone before it has either
produced neighborhood signs or has compressed the
normal gland to produce hypopituitarism. A functioning microadenoma secretes an excess of a particular hormone; we have encountered three
neoplastic cell types that I will describe later.
We owe the transsphenoidal approach to Harvey
Cushing, who took up the procedure because at that
time it was safer than craniotomy. Dr. Cushing,
working with a headlight (looking very much like a
coal miner's lamp) and with a simple speculum,
achieved excellent results. He encountered two
problems-he was viewing a deep, dark hole without
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magnification, and there was a CSF lead and
meningitis without the advantage of antibiotics. A
Frenchman, Guiot, is largely responsible for reintroducing the transsphenoidal procedure. One of his
brilliant students, Jules Hardy, refined the technique,
using the operating microscope and an image intensifier, which allows the operator, during the
procedure, to observe operative maneuvers in the
region of the sella.
The anatomical principles underlying the surgical approach to the pituitary are really two: One is
a sublabial-transnasal-transsphenoidal approach,
maintaining the strict midline which is of great advantage to the surgeon, because he can see equally
well to the right and to the left and he knows that he
is in the midline. The second is the image intensifier in
the lateral projection, because this permits the surgeon to look on the television monitor so that he can
approach the sella between the tuberculum and the
floor; he can see his instruments within the sella, and
he can put air in the ventricul~r systein at the beginning of the operation and watch the third ventricle
pulsate down into its normal position as the
suprasellar component of the tumor is removed. For
maximum safety, the image intensifier is essential.
With experience, one can see and identify the normal
pituitary gland, and the surgeon can be certain that
the suprasellar component has been removed,
because the normal intracranial pressure in a semisitting position forces the stretched diaphragm of the
sella (which we have erroneously referred to as the
tumor capsule in the past) back down into the sella,
so that with a sizable suprasellar extension, one actually ends up with a diaphragm almost pulsating on
the floor of the sella.
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Dr. Hardy has recently suggested that microadenomas of certain cell types occur in preferential sites within the anterior lobe. This has
not been our experience, but his larger experience is
more valid. The endocrinologists with their elegant
techniques can pick up endocrinopathies at an early
stage. Our neuroradiology had to improve to identify a microadenoma, when the endocrinopathy was
defined. This is particularly true, not so much in
acromegaly, but with the galactorrhea-amenorrhea
syndrome and postadrenalectomy Nelson's syndrome.
We are completing a paper on our experience
with the neuroradiology of microadenomas.
Although in the lateral projection, the sella is unremarkable, on plain films, lateral polytome cuts
show an obviously abnormal sella. With A-P
polytome cuts, one can predict the location of the
microadenoma because of depression and thinning of
the floor of the sella. The surgeon can expose the
microadenoma at the site of the focal sellar bulging.
A microadenoma is 1 cm or less in diameter.
These small tumors are ideally suited to transsphenoidal removal. One would not approach a
microadenoma with the classical transfrontal technique, since it is difficult to reach and involves going
through normal anterior pituitary at an awkward
angle to reach the adenoma.
I have removed 60 pituitary tumors by a
transsphenoidal approach; one-half presented with
hyperfunctioning adenomas. My experience with
these tumors has pushed me strongly in two directions: First, we have an extremely active endocrine
group and a large number of acromegalic patients; second, I work with a neuro-ophthalmologist, William
F. Hoyt, who attracts patients with unusual eye
problems, a fair number of whom have pituitary disorders. Approximately one-fourth ~f his patients had
clinical and chemical hypopituitarism at the time of
presentation-I I% complained of visual loss; 7%, of
diplopia; 6%, of headache; and 4% had rhinorrhea .
Regarding visual-field defects-58% had no defect, 32% had bitemporal hemianopsia or some
variation of that, and 10% had some other type of
visual-field defect.
By routine stains, 62% were chromophobe, 36%
eosinophil, and 2% basophil. In the chromophobe
group are some prolactin-secreting adenomas, some
growth hormone-secreting adenomas, and some
ACTH-secreting adenomas. According to functional
types, 40% secreted nothing or, at least, nothing that
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we recognized. I suspect, however, that this number
would be smaller, if we checked every patient for
prolactin levels, because elevated prolactin levels can
exist without any overt clinical manifestation . The
remaining 60% secreted an excess of one hormone:
14% prolactin, 10% ACTH, and the remainder,
growth hormone. All patients with ACTH-secreting
tumors had undergone prior adrenalectomy and
presented with hyper-pigmentation and high ACTH
levels.
With respect to anatomical extent of the tumors,
33% were entirely intrasellar. Some of these were
microadenomas; some were not. Even with very large
sellas, the tumor may be contained within the sella.
The remainder extended beyond the sella-some with
extrasellar extension in more than one direction-42% were suprasellar, 28% had eccentric lateral
extension , and 23% went into the sphenoidal
sinus. The number of sphenoidal and suprasellar
extensions is directly related to the quality of the
neuroradiology.
When we began using the transsphenoidal
technique, we got only the castoffs-patients who
had failed to respond to prior treatment. Ours was
the second team in terms of handling pituitary
problems, but as we demonstrated our ability to handle recurrent tumors, we began seeing primary cases.
As we gain greater experience with the acromegalic patients, we are reducing growth hormone
levels down to very low levels, like 2-3 ng/ml. Not
a single patient, primarily treated for acromegaly,
has developed hypopituitarism following operation. Transsphenoidal removal constitutes excellent
treatment for acromegaly, and we are seeing more
and more patients. We are in the process now
of designing a study which will compare
transsphenoidal removal alone with transsphenoidal
removal plus irradiation. Unless postoperative
growth hormone levels are in the normal range, the
adenoma has not been removed. Because our experience is limited, we do not know how many of
these patients will return with late recurrence.
Patients with Nelson's syndrome have undergone adrenalectomy for Cushing's disease, and at
variable times thereafter, become hyperpigmented.
Many tumors that secrete ACTH are malignant in
the biologic behavior, which is a compelling reason to
make the diagnosis and to treat them radically as
soon as possible.
One of the more interesting facets of the
microadenoma story is the syndrome of galac-
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torrhea and amenorrhea. Historically, three
types of galactorrhea and amenorrhea have
been described, depending upon whether the syndrome appeared following delivery or spontaneously.
The group of interest here is the Forbes-Albright syndrome, which can have its onset either postpartally
or, more often, spontaneously. By definition, the sella
turcica is enlarged, and galactorrhea and amenorrhea
are permanent. The only difference between the
Forbes-Albright and the Del Castillo syndrome is the
normal sella, and here I think it is a matter of time.
These patients have microadenomas, but until one
studies the sella by polytomography, the sella may
appear normal. We now have eight of these
patients-three harbored macroadenomas and the
remainder, microadenomas. These, like the ACTHsecreting adenomas, have a greater liability than the
usual chromophobe adenoma to become invasive.
For some reason, unlike the growth hormonesecreting adenomas or acromegaly, tumors that
secrete prolactin and tumors that secrete ACTH are
inherently bad actors; that is, they have a relatively
high risk of becoming malignant as judged by invasive behavior.
Excluding one patient with an intrasellar
abscess, we have had no operative deaths, and this is
a significant advantage of the technique. We divided the morbidity into major and minor, the major including pneumonitis and rhinorrhea . If we think
that the patient might be developing rhinorrhea, we
treat vigorously in the first five postoperative days; I
am certain that we are overtreating and unnecessarily
treating a number of patients. We insert a lumbar
subarachnoid drain, start Diamox®, and elevate the
head; and our rhinorrhea rate falls very rapidly. Two
patients had transient cranial nerve palsies due to
vigorous use of a curette against the wall of an
already compressed cavernous sinus. One patient had
a postoperative hematoma within the tumor capsule.
This was recognized within four hours, and the
patient was returned to the operating room, where it
was removed with no consequences. Five patients
had diabetes insipidus persisting longer than a month
and four patients had transient diabetes insipid us. An
aseptic meningeal reaction from blood in the CSF,
sinusitis, nose bleed, one corneal abrasion, and
urinary tract infections represented minor complications. In no patient who had either normal or
impaired vision prior to operation was vision made
worse; this makes it a very attractive procedure,
because even with the very best results from the
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transfrontal technique, vision was made worse in an
occasional patient.
The transsphenoidal technique is the procedure
of choice under the following circumstances.
1. Sphenoidal extension;
2. Modest suprasellar extension without lateral
extension: We can handle the direct upward
suprasellar extension. In the last 18 months, I
have operated on 40 pituitary tumors, only
one of which was-done by craniotomy. There
was a suprasellar extension that went laterally
into one frontal lobe, and you simply cannot
turn the corner going through the sphenoid
sinus. Consequently, this patient was done
transfron tally .
3. The patient with paracentral, bitemporal
scotomas: The neuro-ophthalmologist will
assure you that this patient has either a prefixed chiasm or a retrochiasmal nodule.
This presents a difficult problem for the
neurosurgeon operating transfrontally, because the optic nerves are hugging the
tuberculum and there is no room to work
between the optic nerves. This is, in my opinion, an indication, unless there is some contraindication, to the transphenoidal route.
4. The microadenoma (mentioned earlier);
5. Spontaneous rhinorrhea in association with a
pituitary tumor;
6. Pituitary apoplexy: A low morbidity
procedure accomplishes what you want to accomplish very quickly, and since these
patients are often ill and need rapid decompression, I think it is clearly the procedure of
choice for pituitary apoplexy.
7. The patient who is old or debilitated for
whatever reason, or if you simply want to do
a biopsy.
Which tumors should be approached by the
transfrontal technique? Again, this is my own prejudice . The massive suprasellar extension is a huge
mass of intracranial tumor, and what is happening
within and immediately above the sella is really not
the important part of the tumor. I have discussed the
tumor with lateral extension. Perhaps tumors with
massive suprasellar and sphenoidal extensions should
be removed sequentially by both routes. The one contraindication to any major procedure is unequivocal
cavernous sinus invasion. Extraocular motor palsies
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alone are not an indication of invasion. As pointed
out by Sir Geoffrey Jefferson, a fixed sensory loss is
the one clinical sign of cavernous sinus invasion .
In summary, the one thing that is new in
the management of pituitary tumors is the
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transsphenoidal technique. Obviously, there still
remains a place for transfrontal craniotomy and
cryosurgery, but I predict that an increasing number
of pituitary tumors will be done by the
transsphenoidal technique.

